| Yahoo! Health - My Alerts - Edit Alert |
| Monday, Mar 11, 2013 08:11 PM EDT | |
| Glaxo Seeks EU Approval for Eperzan - Analyst Blog Mon, 11 Mar, 2013 04:30 PM PDT GlaxoSmithKline ( GSK ) recently announced the submission of a marketing application to the European Medicines Agency (EMA) for its diabetes candidate Eperzan (albiglutide). The company Hundreds of mourners gather to honor Miracles' Bobby Rogers Mon, 11 Mar, 2013 03:02 PM PDT Several hundred people gathered this morning at Detroit's Tabernacle Missionary Baptist Church for the funeral of Rogers, who died March 3 of complications from diabetes. The Detroit native and Southfield resident was 73. Some Experts Defend Niacin For Heart Disease After Failed Study Mon, 11 Mar, 2013 03:01 PM PDT On Saturday researchers from Oxford University presented data from a 25,673 patient clinical trial funded by Merck that many doctors say should probably end the widespread use of the B vitamin niacin as a heart drug, both because a pill containing extended-release niacin didn't prevent heart attacks and strokes and because it caused increases in diabetes complications, bleeding, and infections. Gilead drug reduces chest pain episodes in diabetics: study Mon, 11 Mar, 2013 01:53 PM PDT SAN FRANCISCO (Reuters) - Gilead Sciences Inc's angina drug Ranexa reduced incidents of chest pain in patients with diabetes, and the effect appeared to be more pronounced in those with poor blood sugar control, according to data from a clinical trial... Drug Shows Potential to Delay Onset or Progression of Alzheimer's Disease Mon, 11 Mar, 2013 01:34 PM PDT An anti-atherosclerosis drug greatly reduced blood-brain barrier (BBB) leaks in animal models with diabetes and hypercholesterolemia and linked BBB permeability with amyloid peptide deposits at the site of early Alzheimer's pathology. J&J Seeks EU Nod for Combo Drug zacks.com Mon, 11 Mar, 2013 01:23 PM PDT Approval of this fixed dose combination would provide type II diabetes patients with a convenient treatment option. | |
|

No comments:
Post a Comment